SAGE - Sage Therapeutics' (SAGE) CEO Barry Greene on Q4 2021 Results - Earnings Call Transcript
Sage Therapeutics, Inc. (SAGE) Q4 2021 Earnings Conference Call February 24, 2022, 8:00 am ET Company Participants Helen Rubinstein - Director, IR Barry Greene - CEO Jim Doherty - CDO Kimi Iguchi - CFO Chris Benecchi - CCO Conference Call Participants Andrea Tan - Goldman Sachs Tiffany Sun - JPMorgan Yasmeen Rahimi - Piper Sandler Laura Chico - Wedbush Securities Ami Fadia - Needham & Company Paul Matteis - Stifel Tazeen Ahmad - Bank of America Yatin Suneja - Guggenheim Douglas Tsao - H.C. Wainwright Matt Hagood - Oppenheimer Sumant Kulkarni - Canaccord Vikram Purohit - Morgan Stanley Presentation Operator Good morning. Welcome to SAGE Therapeutics Fourth Quarter and Full Year 2021 Financial Results Conference Call. Currently, all participants are in listen-only mode. This call is being webcast live on the Investors & Media section of SAGE's website at sagerx.com. This call is the property of SAGE Therapeutics and recordings,
For further details see:
Sage Therapeutics' (SAGE) CEO Barry Greene on Q4 2021 Results - Earnings Call Transcript